| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | kinase binding | SPDYE11 PPP2R5A SPDYE17 SPDYE10 LAT SPDYE15 ABI2 SPDYE3 CHEK2 PAK1 PAK2 SPDYE8 CNKSR2 BCL11A SPDYE12 SPDYE14 IFNAR2 | 3.47e-08 | 969 | 71 | 17 | GO:0019900 |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.97e-07 | 37 | 71 | 5 | GO:0140658 | |
| GeneOntologyMolecularFunction | protein kinase binding | SPDYE11 SPDYE17 SPDYE10 LAT SPDYE15 SPDYE3 CHEK2 PAK1 PAK2 SPDYE8 CNKSR2 BCL11A SPDYE12 SPDYE14 IFNAR2 | 3.34e-07 | 873 | 71 | 15 | GO:0019901 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 8.95e-05 | 127 | 71 | 5 | GO:0008094 | |
| GeneOntologyMolecularFunction | lncRNA binding | 2.60e-04 | 35 | 71 | 3 | GO:0106222 | |
| GeneOntologyMolecularFunction | histone binding | 3.59e-04 | 265 | 71 | 6 | GO:0042393 | |
| GeneOntologyMolecularFunction | RNA polymerase I core promoter sequence-specific DNA binding | 6.72e-04 | 11 | 71 | 2 | GO:0001164 | |
| GeneOntologyMolecularFunction | co-SMAD binding | 8.04e-04 | 12 | 71 | 2 | GO:0070410 | |
| GeneOntologyMolecularFunction | RNA polymerase I transcription regulatory region sequence-specific DNA binding | 9.48e-04 | 13 | 71 | 2 | GO:0001163 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 9.62e-04 | 441 | 71 | 7 | GO:0016887 | |
| GeneOntologyMolecularFunction | small GTPase binding | 9.81e-04 | 321 | 71 | 6 | GO:0031267 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 1.34e-03 | 229 | 71 | 5 | GO:0003714 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.48e-03 | 614 | 71 | 8 | GO:0140657 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.56e-03 | 140 | 71 | 4 | GO:0001221 | |
| GeneOntologyMolecularFunction | GTPase binding | 1.76e-03 | 360 | 71 | 6 | GO:0051020 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 2.41e-03 | 262 | 71 | 5 | GO:0140097 | |
| GeneOntologyMolecularFunction | helicase activity | 2.43e-03 | 158 | 71 | 4 | GO:0004386 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | LAT ABI2 BAZ2A HIP1R SMARCA4 CHD4 ZC3H18 BCL11A KDM1A HNRNPU IFNAR2 | 2.51e-03 | 1160 | 71 | 11 | GO:0030674 |
| GeneOntologyMolecularFunction | p53 binding | 2.61e-03 | 77 | 71 | 3 | GO:0002039 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | LAT CTCF ABI2 BAZ2A HIP1R SMARCA4 CHD4 ZC3H18 BCL11A KDM1A HNRNPU IFNAR2 | 2.80e-03 | 1356 | 71 | 12 | GO:0060090 |
| GeneOntologyMolecularFunction | chromatin DNA binding | 2.97e-03 | 167 | 71 | 4 | GO:0031490 | |
| GeneOntologyMolecularFunction | acetylcholine receptor regulator activity | 4.13e-03 | 27 | 71 | 2 | GO:0030548 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor regulator activity | 4.44e-03 | 28 | 71 | 2 | GO:0099602 | |
| GeneOntologyMolecularFunction | chromatin binding | 4.62e-03 | 739 | 71 | 8 | GO:0003682 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 5.08e-03 | 30 | 71 | 2 | GO:0070577 | |
| GeneOntologyMolecularFunction | transcription factor binding | 5.16e-03 | 753 | 71 | 8 | GO:0008134 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 5.42e-03 | 31 | 71 | 2 | GO:0140033 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 5.63e-03 | 320 | 71 | 5 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 6.08e-03 | 326 | 71 | 5 | GO:0001217 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 6.13e-03 | 33 | 71 | 2 | GO:0050681 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 6.24e-03 | 206 | 71 | 4 | GO:0140030 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase binding | 6.97e-03 | 337 | 71 | 5 | GO:0031625 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | GRWD1 CTCF BAZ2A TET1 RSF1 HASPIN SHPRH PAK1 SMARCA4 CHD8 CHD4 KDM1A HNRNPU | 3.62e-07 | 741 | 64 | 13 | GO:0006338 |
| GeneOntologyBiologicalProcess | chromatin organization | GRWD1 CTCF BAZ2A TET1 RSF1 HASPIN SHPRH PAK1 SMARCA4 CHD8 CHD4 KDM1A HNRNPU BAHCC1 | 4.86e-07 | 896 | 64 | 14 | GO:0006325 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | GRWD1 CTCF BAZ2A TET1 RSF1 HASPIN SHPRH PAK1 SMARCA4 CHD8 CHD4 KDM1A HNRNPU BAHCC1 | 1.77e-06 | 999 | 64 | 14 | GO:0071824 |
| GeneOntologyBiologicalProcess | DNA methylation-dependent constitutive heterochromatin formation | 1.04e-05 | 44 | 64 | 4 | GO:0006346 | |
| GeneOntologyBiologicalProcess | facultative heterochromatin formation | 2.55e-05 | 55 | 64 | 4 | GO:0140718 | |
| GeneOntologyBiologicalProcess | stimulatory C-type lectin receptor signaling pathway | 4.83e-05 | 23 | 64 | 3 | GO:0002223 | |
| GeneOntologyBiologicalProcess | cellular response to lectin | 4.83e-05 | 23 | 64 | 3 | GO:1990858 | |
| GeneOntologyBiologicalProcess | response to lectin | 4.83e-05 | 23 | 64 | 3 | GO:1990840 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | PDE3A CTCF ABI2 YLPM1 HASPIN CHEK2 HIP1R PAK1 SMARCA4 PAK2 PAK3 FHOD3 RABGAP1 HNRNPU | 5.03e-05 | 1342 | 64 | 14 | GO:0033043 |
| GeneOntologyBiologicalProcess | postsynapse organization | 5.13e-05 | 313 | 64 | 7 | GO:0099173 | |
| GeneOntologyBiologicalProcess | dendrite development | 7.86e-05 | 335 | 64 | 7 | GO:0016358 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | CTCF BAZ2A USP9X TET1 YLPM1 RSF1 SMARCA4 CC2D1B CC2D1A CHD8 CHD4 BCL11A KDM1A HNRNPU | 7.89e-05 | 1399 | 64 | 14 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | CTCF USP9X TET1 YLPM1 SMARCA4 CC2D1B CC2D1A CHD8 CHD4 BCL11A KDM1A HNRNPU | 8.25e-05 | 1053 | 64 | 12 | GO:0000122 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | CTCF BAZ2A USP9X TET1 YLPM1 RSF1 SMARCA4 CC2D1B CC2D1A CHD8 CHD4 BCL11A KDM1A HNRNPU | 8.78e-05 | 1413 | 64 | 14 | GO:1902679 |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 9.72e-05 | 239 | 64 | 6 | GO:0071383 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 1.20e-04 | 155 | 64 | 5 | GO:0043401 | |
| GeneOntologyBiologicalProcess | immune response-activating cell surface receptor signaling pathway | 1.21e-04 | 359 | 64 | 7 | GO:0002429 | |
| GeneOntologyBiologicalProcess | heterochromatin formation | 1.52e-04 | 163 | 64 | 5 | GO:0031507 | |
| GeneOntologyBiologicalProcess | immune response-regulating cell surface receptor signaling pathway | 2.11e-04 | 393 | 64 | 7 | GO:0002768 | |
| GeneOntologyBiologicalProcess | synapse organization | 2.51e-04 | 685 | 64 | 9 | GO:0050808 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | ABI2 USP9X CHEK2 HIP1R PAK1 PAK2 PAK3 CC2D1A FHOD3 CHD4 RABGAP1 HNRNPU | 2.57e-04 | 1189 | 64 | 12 | GO:0044087 |
| GeneOntologyBiologicalProcess | primitive erythrocyte differentiation | 2.62e-04 | 8 | 64 | 2 | GO:0060319 | |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | 3.33e-04 | 300 | 64 | 6 | GO:0110053 | |
| GeneOntologyBiologicalProcess | negative regulation of gene expression, epigenetic | 4.18e-04 | 203 | 64 | 5 | GO:0045814 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | WIZ GRWD1 USP9X YLPM1 CHEK2 SHPRH SMARCA4 PAK3 CHD4 KDM1A HNRNPU | 4.49e-04 | 1081 | 64 | 11 | GO:0006259 |
| GeneOntologyBiologicalProcess | RNA polymerase I preinitiation complex assembly | 5.12e-04 | 11 | 64 | 2 | GO:0001188 | |
| GeneOntologyBiologicalProcess | androgen receptor signaling pathway | 5.34e-04 | 51 | 64 | 3 | GO:0030521 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | 5.45e-04 | 605 | 64 | 8 | GO:0071407 | |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | 5.51e-04 | 330 | 64 | 6 | GO:0040029 | |
| GeneOntologyBiologicalProcess | nucleosome assembly | 5.63e-04 | 122 | 64 | 4 | GO:0006334 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell development | 5.63e-04 | 122 | 64 | 4 | GO:0055013 | |
| GeneOntologyBiologicalProcess | chromosome segregation | 5.80e-04 | 465 | 64 | 7 | GO:0007059 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 6.01e-04 | 614 | 64 | 8 | GO:0010720 | |
| GeneOntologyBiologicalProcess | primitive hemopoiesis | 6.13e-04 | 12 | 64 | 2 | GO:0060215 | |
| GeneOntologyBiologicalProcess | cardiac cell development | 7.57e-04 | 132 | 64 | 4 | GO:0055006 | |
| GeneOntologyBiologicalProcess | cell junction organization | 7.84e-04 | 974 | 64 | 10 | GO:0034330 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 7.87e-04 | 802 | 64 | 9 | GO:0048812 | |
| GeneOntologyBiologicalProcess | adherens junction assembly | 8.42e-04 | 14 | 64 | 2 | GO:0034333 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 8.46e-04 | 136 | 64 | 4 | GO:0030518 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 9.12e-04 | 819 | 64 | 9 | GO:0120039 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 9.61e-04 | 244 | 64 | 5 | GO:0009755 | |
| GeneOntologyBiologicalProcess | dendritic spine development | 9.68e-04 | 141 | 64 | 4 | GO:0060996 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 9.69e-04 | 826 | 64 | 9 | GO:0048858 | |
| GeneOntologyBiologicalProcess | nucleosome organization | 9.93e-04 | 142 | 64 | 4 | GO:0034728 | |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | 1.05e-03 | 249 | 64 | 5 | GO:0065004 | |
| GeneOntologyBiologicalProcess | sister chromatid segregation | 1.15e-03 | 254 | 64 | 5 | GO:0000819 | |
| GeneOntologyBiologicalProcess | response to steroid hormone | 1.16e-03 | 381 | 64 | 6 | GO:0048545 | |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | 1.21e-03 | 384 | 64 | 6 | GO:0032956 | |
| GeneOntologyBiologicalProcess | chromosome organization | 1.23e-03 | 686 | 64 | 8 | GO:0051276 | |
| GeneOntologyBiologicalProcess | muscle cell development | 1.25e-03 | 259 | 64 | 5 | GO:0055001 | |
| GeneOntologyBiologicalProcess | lens fiber cell development | 1.40e-03 | 18 | 64 | 2 | GO:0070307 | |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase I promoter | 1.40e-03 | 18 | 64 | 2 | GO:0006361 | |
| GeneOntologyBiologicalProcess | regulation of neuron maturation | 1.40e-03 | 18 | 64 | 2 | GO:0014041 | |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 1.41e-03 | 266 | 64 | 5 | GO:0033044 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 9.67e-06 | 96 | 62 | 5 | GO:0070603 | |
| GeneOntologyCellularComponent | TCR signalosome | 2.59e-05 | 3 | 62 | 2 | GO:0036398 | |
| GeneOntologyCellularComponent | ATPase complex | 4.04e-05 | 129 | 62 | 5 | GO:1904949 | |
| GeneOntologyCellularComponent | chromosomal region | 2.42e-04 | 421 | 62 | 7 | GO:0098687 | |
| GeneOntologyCellularComponent | centrosome | PPP2R5A USP9X HASPIN PAK1 RASSF10 CC2D1A CHD4 RABGAP1 HNRNPU | 4.20e-04 | 770 | 62 | 9 | GO:0005813 |
| GeneOntologyCellularComponent | asymmetric synapse | 5.13e-04 | 477 | 62 | 7 | GO:0032279 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 6.44e-04 | 817 | 62 | 9 | GO:0098978 | |
| GeneOntologyCellularComponent | ISWI-type complex | 7.70e-04 | 14 | 62 | 2 | GO:0031010 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 8.82e-04 | 523 | 62 | 7 | GO:0098984 | |
| GeneOntologyCellularComponent | mitotic spindle midzone | 1.01e-03 | 16 | 62 | 2 | GO:1990023 | |
| GeneOntologyCellularComponent | microtubule organizing center | PPP2R5A USP9X HASPIN PAK1 RASSF10 CC2D1A CHD4 RABGAP1 HNRNPU | 1.47e-03 | 919 | 62 | 9 | GO:0005815 |
| GeneOntologyCellularComponent | male germ cell nucleus | 2.13e-03 | 86 | 62 | 3 | GO:0001673 | |
| GeneOntologyCellularComponent | postsynaptic density | 2.16e-03 | 451 | 62 | 6 | GO:0014069 | |
| GeneOntologyCellularComponent | postsynapse | 2.95e-03 | 1018 | 62 | 9 | GO:0098794 | |
| HumanPheno | Wide nasal base | 1.81e-05 | 28 | 30 | 4 | HP:0012810 | |
| HumanPheno | Abnormal nasal base norphology | 2.41e-05 | 30 | 30 | 4 | HP:0012808 | |
| Domain | PAK_BD | 7.62e-07 | 6 | 64 | 3 | IPR033923 | |
| Domain | SNF2_N | 4.19e-06 | 32 | 64 | 4 | IPR000330 | |
| Domain | SNF2_N | 4.19e-06 | 32 | 64 | 4 | PF00176 | |
| Domain | - | 8.26e-06 | 12 | 64 | 3 | 3.90.810.10 | |
| Domain | DM14 | 1.16e-05 | 2 | 64 | 2 | SM00685 | |
| Domain | DM14 | 1.16e-05 | 2 | 64 | 2 | IPR006608 | |
| Domain | PBD | 2.08e-05 | 16 | 64 | 3 | SM00285 | |
| Domain | PBD | 2.52e-05 | 17 | 64 | 3 | PF00786 | |
| Domain | P-loop_NTPase | ABCA5 HNRNPUL2 YLPM1 SHPRH SMARCA4 CHD8 CHD4 HNRNPUL1 KIF18B HS6ST3 ABCA10 HNRNPU | 2.64e-05 | 848 | 64 | 12 | IPR027417 |
| Domain | CRIB | 4.20e-05 | 20 | 64 | 3 | PS50108 | |
| Domain | CRIB_dom | 4.88e-05 | 21 | 64 | 3 | IPR000095 | |
| Domain | - | 4.88e-05 | 21 | 64 | 3 | 1.10.720.30 | |
| Domain | SAP | 5.64e-05 | 22 | 64 | 3 | PF02037 | |
| Domain | SAP | 6.47e-05 | 23 | 64 | 3 | SM00513 | |
| Domain | SAP | 8.36e-05 | 25 | 64 | 3 | PS50800 | |
| Domain | SAP_dom | 8.36e-05 | 25 | 64 | 3 | IPR003034 | |
| Domain | WHIM1 | 1.15e-04 | 5 | 64 | 2 | PF15612 | |
| Domain | WHIM1_dom | 1.15e-04 | 5 | 64 | 2 | IPR028942 | |
| Domain | BRK | 1.72e-04 | 6 | 64 | 2 | SM00592 | |
| Domain | DDT | 1.72e-04 | 6 | 64 | 2 | PS50827 | |
| Domain | BRK_domain | 1.72e-04 | 6 | 64 | 2 | IPR006576 | |
| Domain | BRK | 1.72e-04 | 6 | 64 | 2 | PF07533 | |
| Domain | - | ABCA5 HNRNPUL2 YLPM1 SHPRH SMARCA4 CHD8 CHD4 HNRNPUL1 ABCA10 HNRNPU | 2.09e-04 | 746 | 64 | 10 | 3.40.50.300 |
| Domain | WASP_C | 2.40e-04 | 7 | 64 | 2 | IPR011026 | |
| Domain | PHD | 2.46e-04 | 89 | 64 | 4 | SM00249 | |
| Domain | Znf_PHD | 2.68e-04 | 91 | 64 | 4 | IPR001965 | |
| Domain | ZF_PHD_2 | 3.16e-04 | 95 | 64 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 3.29e-04 | 96 | 64 | 4 | PS01359 | |
| Domain | Helicase_C | 4.97e-04 | 107 | 64 | 4 | PF00271 | |
| Domain | HELICc | 4.97e-04 | 107 | 64 | 4 | SM00490 | |
| Domain | Helicase_C | 5.14e-04 | 108 | 64 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 5.33e-04 | 109 | 64 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 5.33e-04 | 109 | 64 | 4 | PS51192 | |
| Domain | DEXDc | 5.33e-04 | 109 | 64 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 5.51e-04 | 110 | 64 | 4 | IPR014001 | |
| Domain | ABC_A | 7.46e-04 | 12 | 64 | 2 | IPR026082 | |
| Domain | Zinc_finger_PHD-type_CS | 1.44e-03 | 65 | 64 | 3 | IPR019786 | |
| Domain | Znf_FYVE_PHD | 1.62e-03 | 147 | 64 | 4 | IPR011011 | |
| Domain | PHD | 2.17e-03 | 75 | 64 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 2.52e-03 | 79 | 64 | 3 | IPR019787 | |
| Domain | Chromo_domain | 3.04e-03 | 24 | 64 | 2 | IPR023780 | |
| Domain | SPRY | 3.31e-03 | 87 | 64 | 3 | SM00449 | |
| Domain | Bromodomain_CS | 3.56e-03 | 26 | 64 | 2 | IPR018359 | |
| Domain | - | 3.56e-03 | 26 | 64 | 2 | 1.25.40.90 | |
| Domain | Chromo | 3.56e-03 | 26 | 64 | 2 | PF00385 | |
| Domain | SPRY | 4.12e-03 | 94 | 64 | 3 | PF00622 | |
| Domain | SPRY_dom | 4.12e-03 | 94 | 64 | 3 | IPR003877 | |
| Domain | CHROMO_1 | 4.13e-03 | 28 | 64 | 2 | PS00598 | |
| Domain | CHROMO_2 | 4.13e-03 | 28 | 64 | 2 | PS50013 | |
| Domain | B30.2/SPRY | 4.24e-03 | 95 | 64 | 3 | IPR001870 | |
| Domain | B302_SPRY | 4.24e-03 | 95 | 64 | 3 | PS50188 | |
| Domain | ENTH_VHS | 4.42e-03 | 29 | 64 | 2 | IPR008942 | |
| Domain | Chromodomain-like | 5.37e-03 | 32 | 64 | 2 | IPR016197 | |
| Domain | Chromo/shadow_dom | 5.70e-03 | 33 | 64 | 2 | IPR000953 | |
| Domain | CHROMO | 5.70e-03 | 33 | 64 | 2 | SM00298 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 6.39e-03 | 35 | 64 | 2 | IPR002464 | |
| Pathway | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | 2.26e-08 | 27 | 46 | 5 | MM14809 | |
| Pathway | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | 1.57e-07 | 39 | 46 | 5 | M16523 | |
| Pathway | REACTOME_CD28_DEPENDENT_VAV1_PATHWAY | 7.01e-06 | 12 | 46 | 3 | M13618 | |
| Pathway | REACTOME_CD28_DEPENDENT_VAV1_PATHWAY | 7.01e-06 | 12 | 46 | 3 | MM14994 | |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 7.51e-06 | 39 | 46 | 4 | MM15607 | |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 8.32e-06 | 40 | 46 | 4 | M41816 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1 | 9.09e-06 | 13 | 46 | 3 | M6322 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 1.15e-05 | 14 | 46 | 3 | MM15029 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 1.77e-05 | 16 | 46 | 3 | M16498 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 2.14e-05 | 17 | 46 | 3 | MM15215 | |
| Pathway | REACTOME_EPHRIN_SIGNALING | 2.56e-05 | 18 | 46 | 3 | MM15024 | |
| Pathway | KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY | 2.57e-05 | 108 | 46 | 5 | M9904 | |
| Pathway | REACTOME_TCR_SIGNALING | 2.93e-05 | 111 | 46 | 5 | MM14803 | |
| Pathway | REACTOME_EPHRIN_SIGNALING | 3.04e-05 | 19 | 46 | 3 | M27310 | |
| Pathway | WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA | 3.96e-05 | 59 | 46 | 4 | M39750 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 4.15e-05 | 21 | 46 | 3 | M27485 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 4.15e-05 | 21 | 46 | 3 | M27494 | |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | 4.23e-05 | 60 | 46 | 4 | MM14913 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 4.94e-05 | 301 | 46 | 7 | MM15983 | |
| Pathway | REACTOME_TCR_SIGNALING | 4.99e-05 | 124 | 46 | 5 | M15381 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 5.50e-05 | 23 | 46 | 3 | MM15222 | |
| Pathway | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 6.17e-05 | 66 | 46 | 4 | MM14990 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 9.00e-05 | 27 | 46 | 3 | M27422 | |
| Pathway | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 9.66e-05 | 74 | 46 | 4 | M17386 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPH_TO_TCR_NFAT_SIGNALING_PATHWAY | 1.04e-04 | 5 | 46 | 2 | M48994 | |
| Pathway | PID_P38_ALPHA_BETA_PATHWAY | 1.24e-04 | 30 | 46 | 3 | M76 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 1.24e-04 | 30 | 46 | 3 | MM15170 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 1.37e-04 | 31 | 46 | 3 | MM1343 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 1.66e-04 | 33 | 46 | 3 | M6220 | |
| Pathway | REACTOME_CD28_CO_STIMULATION | 1.66e-04 | 33 | 46 | 3 | M11725 | |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | 1.81e-04 | 87 | 46 | 4 | M27205 | |
| Pathway | REACTOME_CD28_CO_STIMULATION | 1.81e-04 | 34 | 46 | 3 | MM14992 | |
| Pathway | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | 1.98e-04 | 35 | 46 | 3 | M16801 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 2.34e-04 | 37 | 46 | 3 | M41819 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 2.34e-04 | 37 | 46 | 3 | MM15610 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT | 2.95e-04 | 40 | 46 | 3 | M39798 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 3.47e-04 | 103 | 46 | 4 | MM14752 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER | 3.66e-04 | 43 | 46 | 3 | M39788 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 3.87e-04 | 106 | 46 | 4 | M27077 | |
| Pathway | SIG_CHEMOTAXIS | 4.19e-04 | 45 | 46 | 3 | M5193 | |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 4.77e-04 | 47 | 46 | 3 | M39829 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | 5.51e-04 | 318 | 46 | 6 | MM15278 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 5.98e-04 | 323 | 46 | 6 | M27080 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 6.07e-04 | 51 | 46 | 3 | MM14967 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | 6.38e-04 | 327 | 46 | 6 | M27565 | |
| Pathway | PID_RAC1_PATHWAY | 7.18e-04 | 54 | 46 | 3 | M278 | |
| Pathway | REACTOME_RHOJ_GTPASE_CYCLE | 7.58e-04 | 55 | 46 | 3 | M41815 | |
| Pathway | PID_TCR_JNK_PATHWAY | 9.25e-04 | 14 | 46 | 2 | M190 | |
| Pathway | PID_FCER1_PATHWAY | 9.77e-04 | 60 | 46 | 3 | M7 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 1.02e-03 | 137 | 46 | 4 | M5669 | |
| Pathway | WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION | 1.07e-03 | 62 | 46 | 3 | M39429 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 1.18e-03 | 64 | 46 | 3 | M7923 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 1.23e-03 | 65 | 46 | 3 | MM14911 | |
| Pathway | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | 1.35e-03 | 67 | 46 | 3 | M295 | |
| Pathway | WP_REGULATION_OF_ACTIN_CYTOSKELETON | 1.42e-03 | 150 | 46 | 4 | M39520 | |
| Pathway | REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING | 1.42e-03 | 150 | 46 | 4 | MM14889 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 1.44e-03 | 257 | 46 | 5 | MM14755 | |
| Pathway | WP_REGULATION_OF_ACTIN_CYTOSKELETON | 1.49e-03 | 152 | 46 | 4 | MM15834 | |
| Pathway | KEGG_RENAL_CELL_CARCINOMA | 1.53e-03 | 70 | 46 | 3 | M13266 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 1.54e-03 | 18 | 46 | 2 | M524 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 1.72e-03 | 19 | 46 | 2 | M47733 | |
| Pathway | REACTOME_MAPK6_MAPK4_SIGNALING | 1.72e-03 | 73 | 46 | 3 | MM15285 | |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 1.91e-03 | 20 | 46 | 2 | M16355 | |
| Pathway | REACTOME_VXPX_CARGO_TARGETING_TO_CILIUM | 1.91e-03 | 20 | 46 | 2 | MM15208 | |
| Pathway | REACTOME_VXPX_CARGO_TARGETING_TO_CILIUM | 2.10e-03 | 21 | 46 | 2 | M27479 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 2.49e-03 | 175 | 46 | 4 | MM15599 | |
| Pathway | KEGG_ERBB_SIGNALING_PATHWAY | 2.85e-03 | 87 | 46 | 3 | M12467 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 2.85e-03 | 87 | 46 | 3 | MM15600 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 2.94e-03 | 88 | 46 | 3 | M41810 | |
| Pathway | WP_TCELL_ACTIVATION_SARSCOV2 | 2.94e-03 | 88 | 46 | 3 | M42580 | |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 2.98e-03 | 25 | 46 | 2 | MM1465 | |
| Pathway | PID_MYC_PATHWAY | 2.98e-03 | 25 | 46 | 2 | M139 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 2.99e-03 | 184 | 46 | 4 | M41809 | |
| Pathway | WP_RAS_SIGNALING | 2.99e-03 | 184 | 46 | 4 | M39764 | |
| Pathway | WP_PANCREATIC_ADENOCARCINOMA_PATHWAY | 3.04e-03 | 89 | 46 | 3 | M39732 | |
| Pathway | REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING | 3.11e-03 | 186 | 46 | 4 | M27175 | |
| Pathway | WP_TCELL_RECEPTOR_SIGNALING | 3.13e-03 | 90 | 46 | 3 | M39725 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 3.33e-03 | 92 | 46 | 3 | M27201 | |
| Pathway | WP_ERBB_SIGNALING | 3.33e-03 | 92 | 46 | 3 | M39715 | |
| Pathway | REACTOME_MAPK6_MAPK4_SIGNALING | 3.44e-03 | 93 | 46 | 3 | M27572 | |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 3.44e-03 | 93 | 46 | 3 | MM15609 | |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 3.54e-03 | 94 | 46 | 3 | M41818 | |
| Pathway | BIOCARTA_TNFR1_PATHWAY | 3.73e-03 | 28 | 46 | 2 | MM1516 | |
| Pathway | BIOCARTA_FAS_PATHWAY | 3.73e-03 | 28 | 46 | 2 | MM1396 | |
| Pathway | REACTOME_DAP12_SIGNALING | 4.00e-03 | 29 | 46 | 2 | M27171 | |
| Pathway | BIOCARTA_TNFR1_PATHWAY | 4.00e-03 | 29 | 46 | 2 | M3618 | |
| Pathway | BIOCARTA_FAS_PATHWAY | 4.28e-03 | 30 | 46 | 2 | M9503 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 4.46e-03 | 102 | 46 | 3 | M39577 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 4.46e-03 | 102 | 46 | 3 | MM15830 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_BROWN_AND_BEIGE_ADIPOCYTE_DIFFERENTIATION | 4.56e-03 | 31 | 46 | 2 | M48258 | |
| Pathway | REACTOME_DAP12_SIGNALING | 4.56e-03 | 31 | 46 | 2 | MM14886 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 4.58e-03 | 103 | 46 | 3 | M758 | |
| Pathway | WP_PRION_DISEASE_PATHWAY | 4.85e-03 | 32 | 46 | 2 | M39636 | |
| Pathway | KEGG_REGULATION_OF_ACTIN_CYTOSKELETON | 5.03e-03 | 213 | 46 | 4 | M18306 | |
| Pathway | WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER | 5.50e-03 | 110 | 46 | 3 | M48043 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 5.78e-03 | 112 | 46 | 3 | MM15214 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 5.79e-03 | 35 | 46 | 2 | MM15114 | |
| Pathway | REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE | 5.79e-03 | 35 | 46 | 2 | M918 | |
| Pathway | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | 5.79e-03 | 35 | 46 | 2 | MM14512 | |
| Pathway | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | 5.79e-03 | 35 | 46 | 2 | M773 | |
| Pubmed | MIA3 WIZ HNRNPUL2 CTCF ABI2 USP9X YLPM1 PAK1 SMARCA4 PAK2 PAK3 CHD8 CNKSR2 CHD4 BCL11A KDM1A HNRNPU | 1.19e-11 | 963 | 73 | 17 | 28671696 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 1.05e-09 | 150 | 73 | 8 | 28242625 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | PCF11 MIA3 HNRNPUL2 USP9X YLPM1 HASPIN SMARCA4 CHD8 CHD4 HNRNPUL1 KDM1A | 2.07e-09 | 440 | 73 | 11 | 34244565 |
| Pubmed | 2.26e-09 | 103 | 73 | 7 | 32744500 | ||
| Pubmed | Multisite autophosphorylation of p21-activated protein kinase gamma-PAK as a function of activation. | 8.87e-09 | 3 | 73 | 3 | 10075701 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 15182717 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 23335370 | ||
| Pubmed | Group I Paks as therapeutic targets in NF2-deficient meningioma. | 8.87e-09 | 3 | 73 | 3 | 25596744 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 18507705 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 38785043 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 11278486 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PCF11 WIZ CTCF BAZ2A PRCC YLPM1 RSF1 SMARCA4 CHD8 CHD4 ZC3H18 HNRNPUL1 KIF18B HNRNPU | 1.02e-08 | 954 | 73 | 14 | 36373674 |
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 10461188 | ||
| Pubmed | CHL1 cooperates with PAK1-3 to regulate morphological differentiation of embryonic cortical neurons. | 3.54e-08 | 4 | 73 | 3 | 19819308 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | PCF11 WIZ PRCC YLPM1 HIP1R PAK1 SMARCA4 CHD8 CHD4 KDM1A HNRNPU | 3.66e-08 | 582 | 73 | 11 | 20467437 |
| Pubmed | Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486. | 8.84e-08 | 5 | 73 | 3 | 23509247 | |
| Pubmed | CTCF BAZ2A USP9X YLPM1 RSF1 SMARCA4 CHD8 CHD4 ZC3H18 HNRNPUL1 KDM1A | 1.17e-07 | 653 | 73 | 11 | 22586326 | |
| Pubmed | 1.53e-07 | 23 | 73 | 4 | 30992372 | ||
| Pubmed | 1.71e-07 | 116 | 73 | 6 | 21549307 | ||
| Pubmed | 1.77e-07 | 6 | 73 | 3 | 12237306 | ||
| Pubmed | 1.77e-07 | 6 | 73 | 3 | 33482876 | ||
| Pubmed | Pak1 is involved in dendrite initiation as a downstream effector of Rac1 in cortical neurons. | 1.77e-07 | 6 | 73 | 3 | 12213441 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 2.05e-07 | 411 | 73 | 9 | 35182466 | |
| Pubmed | 2.14e-07 | 199 | 73 | 7 | 36688959 | ||
| Pubmed | 2.26e-07 | 549 | 73 | 10 | 38280479 | ||
| Pubmed | PCF11 WIZ GRWD1 SMARCA4 PAK2 CC2D1A CHD8 CHD4 BCL11A UBXN1 HNRNPUL1 KDM1A HNRNPU | 4.53e-07 | 1103 | 73 | 13 | 34189442 | |
| Pubmed | PPP2R5A WIZ CTCF BAZ2A RSF1 SMARCA4 CHD8 CHD4 ZC3H18 BCL11A KIF18B KDM1A BAHCC1 | 5.16e-07 | 1116 | 73 | 13 | 31753913 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | WIZ CTCF BAZ2A PRCC YLPM1 RSF1 SMARCA4 PAK2 CC2D1A CHD4 HNRNPUL1 HNRNPU | 5.36e-07 | 934 | 73 | 12 | 33916271 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 5.72e-07 | 608 | 73 | 10 | 36089195 | |
| Pubmed | 8.43e-07 | 244 | 73 | 7 | 29884807 | ||
| Pubmed | 1.02e-06 | 251 | 73 | 7 | 31076518 | ||
| Pubmed | HIV-1 Nef: a multifaceted modulator of T cell receptor signaling. | 1.05e-06 | 10 | 73 | 3 | 23227982 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 1.12e-06 | 370 | 73 | 8 | 22922362 | |
| Pubmed | HNRNPUL2 CTCF YLPM1 RSF1 SMARCA4 PAK2 CHD8 CHD4 ZC3H18 RABGAP1 UBXN1 KDM1A | 1.27e-06 | 1014 | 73 | 12 | 32416067 | |
| Pubmed | PCF11 WIZ HNRNPUL2 CTCF PRCC USP9X YLPM1 SMARCA4 CC2D1A CHD8 ZC3H18 BCL11A HNRNPUL1 KDM1A | 1.40e-06 | 1429 | 73 | 14 | 35140242 | |
| Pubmed | 1.45e-06 | 11 | 73 | 3 | 10352232 | ||
| Pubmed | 1.58e-06 | 268 | 73 | 7 | 33640491 | ||
| Pubmed | 1.93e-06 | 12 | 73 | 3 | 18824165 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 2.26e-06 | 283 | 73 | 7 | 30585729 | |
| Pubmed | 2.44e-06 | 411 | 73 | 8 | 36652389 | ||
| Pubmed | Loss of ARHGEF6 Causes Hair Cell Stereocilia Deficits and Hearing Loss in Mice. | 2.50e-06 | 13 | 73 | 3 | 30333726 | |
| Pubmed | 3.18e-06 | 14 | 73 | 3 | 18586681 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 3.68e-06 | 583 | 73 | 9 | 29844126 | |
| Pubmed | Activation of PAK1/2 during the shedding of platelet microvesicles. | 4.35e-06 | 2 | 73 | 2 | 20523167 | |
| Pubmed | Purification of two isoforms of hnRNP-U and characterization of their nucleic acid binding activity. | 4.35e-06 | 2 | 73 | 2 | 8068679 | |
| Pubmed | PAK1, PAK1Δ15, and PAK2: similarities, differences and mutual interactions. | 4.35e-06 | 2 | 73 | 2 | 31748572 | |
| Pubmed | CTCF-dependent chromatin insulator is linked to epigenetic remodeling. | 4.35e-06 | 2 | 73 | 2 | 16949368 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 17084358 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 23622267 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 30732858 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 19435845 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 10712938 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 30858169 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 21115725 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 19380761 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 33034024 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 12925892 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 15047871 | ||
| Pubmed | Expression of p21-activated kinases 1 and 3 is altered in the brain of subjects with depression. | 4.35e-06 | 2 | 73 | 2 | 27474226 | |
| Pubmed | Ubiquitin-specific protease activity of USP9Y, a male infertility gene on the Y chromosome. | 4.35e-06 | 2 | 73 | 2 | 12895410 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 29552027 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 23796711 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 11841396 | ||
| Pubmed | Development of nanoscale structure in LAT-based signaling complexes. | 4.35e-06 | 2 | 73 | 2 | 27875277 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 33255744 | ||
| Pubmed | The Freud-1/CC2D1A family: transcriptional regulators implicated in mental retardation. | 4.35e-06 | 2 | 73 | 2 | 17394259 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 32597567 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 31391252 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 34750857 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 22365830 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 22815483 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 15699071 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 8922996 | ||
| Pubmed | Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells. | 4.35e-06 | 2 | 73 | 2 | 9395435 | |
| Pubmed | Pak1 and Pak2 mediate tumor cell invasion through distinct signaling mechanisms. | 4.35e-06 | 2 | 73 | 2 | 18411304 | |
| Pubmed | Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer. | 4.48e-06 | 52 | 73 | 4 | 24591637 | |
| Pubmed | 4.87e-06 | 16 | 73 | 3 | 20067919 | ||
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 6.19e-06 | 330 | 73 | 7 | 33301849 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 7.15e-06 | 220 | 73 | 6 | 35785414 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 7.66e-06 | 341 | 73 | 7 | 32971831 | |
| Pubmed | 8.59e-06 | 131 | 73 | 5 | 34551306 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 9.24e-06 | 351 | 73 | 7 | 38297188 | |
| Pubmed | 9.37e-06 | 655 | 73 | 9 | 35819319 | ||
| Pubmed | 1.07e-05 | 503 | 73 | 8 | 16964243 | ||
| Pubmed | Group I Paks Promote Skeletal Myoblast Differentiation In Vivo and In Vitro. | 1.30e-05 | 3 | 73 | 2 | 27920252 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 22162999 | ||
| Pubmed | Prognostic significance of PAK family kinases in acute myeloid leukemia. | 1.30e-05 | 3 | 73 | 2 | 30890765 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 20606011 | ||
| Pubmed | Freud-2/CC2D1B mediates dual repression of the serotonin-1A receptor gene. | 1.30e-05 | 3 | 73 | 2 | 21155902 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 25499215 | ||
| Pubmed | Clathrin-independent endocytosis used by the IL-2 receptor is regulated by Rac1, Pak1 and Pak2. | 1.30e-05 | 3 | 73 | 2 | 18344974 | |
| Pubmed | Differential requirement for LAT and SLP-76 in GPVI versus T cell receptor signaling. | 1.30e-05 | 3 | 73 | 2 | 11901197 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 12847255 | ||
| Pubmed | Late-onset megaconial myopathy in mice lacking group I Paks. | 1.30e-05 | 3 | 73 | 2 | 30791960 | |
| Pubmed | The chromatin-remodeling enzymes BRG1 and CHD4 antagonistically regulate vascular Wnt signaling. | 1.30e-05 | 3 | 73 | 2 | 22290435 | |
| Pubmed | PAK1 and PAK2 have different roles in HGF-induced morphological responses. | 1.30e-05 | 3 | 73 | 2 | 19628037 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 34075397 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 28863138 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 11607830 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 26711177 | ||
| Interaction | H3C1 interactions | WIZ GRWD1 HNRNPUL2 CTCF BAZ2A RSF1 HASPIN SHPRH PAK1 SMARCA4 CHD8 CHD4 KIF18B KDM1A HNRNPU | 1.30e-07 | 901 | 65 | 15 | int:H3C1 |
| Interaction | H2BC21 interactions | WIZ TET1 RSF1 SHPRH SMARCA4 CC2D1B CHD8 CHD4 ZC3H18 KIF18B KDM1A HNRNPU BAHCC1 | 2.79e-07 | 696 | 65 | 13 | int:H2BC21 |
| Interaction | H2AX interactions | WIZ HNRNPUL2 CTCF BAZ2A RSF1 CHEK2 PAK1 SMARCA4 CC2D1A CHD8 CHD4 ZC3H18 | 3.66e-07 | 593 | 65 | 12 | int:H2AX |
| Interaction | SIRT6 interactions | PCF11 MIA3 WIZ HNRNPUL2 USP9X YLPM1 HASPIN SMARCA4 CHD8 CHD4 HNRNPUL1 KDM1A | 6.72e-07 | 628 | 65 | 12 | int:SIRT6 |
| Interaction | SAP30 interactions | 1.10e-06 | 167 | 65 | 7 | int:SAP30 | |
| Interaction | TERF2IP interactions | PCF11 WIZ CTCF BAZ2A PRCC RSF1 SMARCA4 CHD8 ZC3H18 KDM1A HNRNPU | 1.38e-06 | 552 | 65 | 11 | int:TERF2IP |
| Interaction | MACROH2A1 interactions | 1.95e-06 | 458 | 65 | 10 | int:MACROH2A1 | |
| Interaction | NCK2 interactions | 1.95e-06 | 262 | 65 | 8 | int:NCK2 | |
| Interaction | SMC5 interactions | PCF11 WIZ CTCF BAZ2A PRCC YLPM1 RSF1 SMARCA4 CHD8 CHD4 ZC3H18 HNRNPUL1 KIF18B HNRNPU | 2.86e-06 | 1000 | 65 | 14 | int:SMC5 |
| Interaction | H3C3 interactions | 3.89e-06 | 495 | 65 | 10 | int:H3C3 | |
| Interaction | RBBP7 interactions | HNRNPUL2 CTCF TET1 SHPRH SMARCA4 CHD4 ZC3H18 BCL11A KDM1A BAHCC1 | 4.81e-06 | 507 | 65 | 10 | int:RBBP7 |
| Interaction | NR4A1 interactions | 5.36e-06 | 212 | 65 | 7 | int:NR4A1 | |
| Interaction | GATA4 interactions | 6.51e-06 | 411 | 65 | 9 | int:GATA4 | |
| Interaction | CHD4 interactions | WIZ GRWD1 HNRNPUL2 BAZ2A YLPM1 RSF1 SHPRH SMARCA4 CHD4 ZC3H18 BCL11A KDM1A HNRNPU | 7.66e-06 | 938 | 65 | 13 | int:CHD4 |
| Interaction | FXR1 interactions | MIA3 HNRNPUL2 CTCF USP9X PAK1 SMARCA4 PAK2 PAK3 GRIP2 HNRNPUL1 HNRNPU | 1.00e-05 | 679 | 65 | 11 | int:FXR1 |
| Interaction | RBBP4 interactions | HNRNPUL2 CTCF SHPRH SMARCA4 RASSF10 CHD4 ZC3H18 BCL11A KDM1A BAHCC1 | 1.40e-05 | 573 | 65 | 10 | int:RBBP4 |
| Interaction | H2BC8 interactions | 1.46e-05 | 576 | 65 | 10 | int:H2BC8 | |
| Interaction | CEP57 interactions | 1.52e-05 | 165 | 65 | 6 | int:CEP57 | |
| Interaction | SIRT7 interactions | CTCF BAZ2A USP9X YLPM1 RSF1 SMARCA4 CHD8 CHD4 ZC3H18 HNRNPUL1 KDM1A | 2.34e-05 | 744 | 65 | 11 | int:SIRT7 |
| Interaction | SNW1 interactions | PCF11 WIZ HIP1R PAK1 PAK2 CHD8 CHD4 ZC3H18 RABGAP1 HNRNPUL1 HNRNPU | 2.43e-05 | 747 | 65 | 11 | int:SNW1 |
| Interaction | H2AZ1 interactions | 2.47e-05 | 371 | 65 | 8 | int:H2AZ1 | |
| Interaction | EWSR1 interactions | PCF11 MIA3 WIZ GRWD1 PRCC RSF1 HIP1R SMARCA4 CHD4 ZC3H18 HNRNPUL1 HNRNPU | 2.83e-05 | 906 | 65 | 12 | int:EWSR1 |
| Interaction | GATA3 interactions | 3.09e-05 | 187 | 65 | 6 | int:GATA3 | |
| Interaction | CEBPA interactions | PCF11 WIZ GRWD1 HNRNPUL2 SMARCA4 PAK2 CC2D1A CHD8 CHD4 BCL11A UBXN1 HNRNPUL1 KDM1A HNRNPU | 3.42e-05 | 1245 | 65 | 14 | int:CEBPA |
| Interaction | YAP1 interactions | BAZ2A USP9X TET1 YLPM1 SMARCA4 PAK2 CC2D1A CHD8 CNKSR2 CHD4 HNRNPUL1 KDM1A HNRNPU | 3.93e-05 | 1095 | 65 | 13 | int:YAP1 |
| Interaction | SMARCAD1 interactions | 4.13e-05 | 197 | 65 | 6 | int:SMARCAD1 | |
| Interaction | EED interactions | WIZ HNRNPUL2 CTCF BAZ2A USP9X YLPM1 SHPRH SMARCA4 PAK2 CHD4 BCL11A HNRNPUL1 KIF18B KDM1A HNRNPU | 4.31e-05 | 1445 | 65 | 15 | int:EED |
| Interaction | MATR3 interactions | GRWD1 HNRNPUL2 USP9X YLPM1 HASPIN CHD4 ZC3H18 HNRNPUL1 USP9Y HNRNPU | 4.38e-05 | 655 | 65 | 10 | int:MATR3 |
| Interaction | MBD3 interactions | 4.52e-05 | 295 | 65 | 7 | int:MBD3 | |
| Interaction | SMARCA5 interactions | 5.47e-05 | 415 | 65 | 8 | int:SMARCA5 | |
| Interaction | NAA40 interactions | WIZ CTCF BAZ2A PRCC YLPM1 RSF1 SMARCA4 PAK2 CC2D1A CHD4 HNRNPUL1 HNRNPU | 5.94e-05 | 978 | 65 | 12 | int:NAA40 |
| Interaction | FOXP3 interactions | 7.24e-05 | 432 | 65 | 8 | int:FOXP3 | |
| Interaction | H4C6 interactions | 7.28e-05 | 69 | 65 | 4 | int:H4C6 | |
| Interaction | SMG7 interactions | 7.39e-05 | 319 | 65 | 7 | int:SMG7 | |
| Interaction | CUL4A interactions | MIA3 GRWD1 USP9X TET1 RSF1 CHEK2 SMARCA4 CHD4 UBXN1 HNRNPUL1 ABCA10 | 8.17e-05 | 854 | 65 | 11 | int:CUL4A |
| Interaction | CDC5L interactions | GRWD1 HNRNPUL2 PRCC YLPM1 HIP1R SMARCA4 CHD8 CHD4 ZC3H18 KDM1A HNRNPU | 8.26e-05 | 855 | 65 | 11 | int:CDC5L |
| Interaction | BCL11B interactions | 9.57e-05 | 74 | 65 | 4 | int:BCL11B | |
| Interaction | POLR1E interactions | 1.32e-04 | 350 | 65 | 7 | int:POLR1E | |
| Interaction | KPNA1 interactions | 1.34e-04 | 351 | 65 | 7 | int:KPNA1 | |
| Interaction | FOXE1 interactions | 1.36e-04 | 81 | 65 | 4 | int:FOXE1 | |
| Interaction | SRPK1 interactions | 1.44e-04 | 477 | 65 | 8 | int:SRPK1 | |
| Interaction | KPNA3 interactions | 1.47e-04 | 248 | 65 | 6 | int:KPNA3 | |
| Interaction | PYHIN1 interactions | 1.51e-04 | 358 | 65 | 7 | int:PYHIN1 | |
| Interaction | NANOG interactions | 1.52e-04 | 481 | 65 | 8 | int:NANOG | |
| Interaction | MYH10 interactions | 1.54e-04 | 359 | 65 | 7 | int:MYH10 | |
| Interaction | SHC1 interactions | 1.62e-04 | 362 | 65 | 7 | int:SHC1 | |
| Interaction | CEBPB interactions | NIBAN1 GRWD1 CTCF BAZ2A PRCC YLPM1 RSF1 SMARCA4 PAK2 CHD4 UBXN1 HNRNPUL1 KDM1A HNRNPU | 1.67e-04 | 1443 | 65 | 14 | int:CEBPB |
| Interaction | MOB3C interactions | 1.68e-04 | 364 | 65 | 7 | int:MOB3C | |
| Interaction | POLR1G interactions | 1.70e-04 | 489 | 65 | 8 | int:POLR1G | |
| Interaction | MBD2 interactions | 1.72e-04 | 161 | 65 | 5 | int:MBD2 | |
| Interaction | HDAC1 interactions | WIZ CTCF BAZ2A TET1 SMARCA4 CHD8 CHD4 RABGAP1 BCL11A KDM1A HNRNPU BAHCC1 | 1.93e-04 | 1108 | 65 | 12 | int:HDAC1 |
| Interaction | SNRNP40 interactions | 1.96e-04 | 637 | 65 | 9 | int:SNRNP40 | |
| Interaction | PHAX interactions | 2.03e-04 | 167 | 65 | 5 | int:PHAX | |
| Interaction | CBX3 interactions | 2.17e-04 | 646 | 65 | 9 | int:CBX3 | |
| Interaction | SIN3A interactions | 2.18e-04 | 380 | 65 | 7 | int:SIN3A | |
| Interaction | CSNK2A1 interactions | MS4A1 PRCC RSF1 CHEK2 PAK1 SMARCA4 RASSF10 CNKSR2 CHD4 ZC3H18 KDM1A | 2.20e-04 | 956 | 65 | 11 | int:CSNK2A1 |
| Interaction | XRN2 interactions | 2.22e-04 | 381 | 65 | 7 | int:XRN2 | |
| Interaction | MKI67 interactions | 2.23e-04 | 648 | 65 | 9 | int:MKI67 | |
| Interaction | KAT6A interactions | 2.27e-04 | 510 | 65 | 8 | int:KAT6A | |
| Interaction | GIT1 interactions | 2.33e-04 | 172 | 65 | 5 | int:GIT1 | |
| Interaction | PHF1 interactions | 2.33e-04 | 172 | 65 | 5 | int:PHF1 | |
| Interaction | FOXG1 interactions | 2.52e-04 | 95 | 65 | 4 | int:FOXG1 | |
| Interaction | KPNA2 interactions | 2.55e-04 | 519 | 65 | 8 | int:KPNA2 | |
| Interaction | TOP2A interactions | 2.58e-04 | 520 | 65 | 8 | int:TOP2A | |
| Interaction | CRNKL1 interactions | 2.66e-04 | 177 | 65 | 5 | int:CRNKL1 | |
| Interaction | CIC interactions | 2.94e-04 | 673 | 65 | 9 | int:CIC | |
| Interaction | TFCP2L1 interactions | 2.95e-04 | 99 | 65 | 4 | int:TFCP2L1 | |
| Interaction | FMR1 interactions | 3.17e-04 | 536 | 65 | 8 | int:FMR1 | |
| Interaction | SNRNP27 interactions | 3.19e-04 | 184 | 65 | 5 | int:SNRNP27 | |
| Interaction | CBX1 interactions | 3.29e-04 | 288 | 65 | 6 | int:CBX1 | |
| Interaction | SMC3 interactions | 3.35e-04 | 408 | 65 | 7 | int:SMC3 | |
| Interaction | HNRNPUL2 interactions | 3.48e-04 | 291 | 65 | 6 | int:HNRNPUL2 | |
| Interaction | EHMT1 interactions | 3.52e-04 | 188 | 65 | 5 | int:EHMT1 | |
| Interaction | SMARCA1 interactions | 3.52e-04 | 188 | 65 | 5 | int:SMARCA1 | |
| Interaction | BACC1 interactions | 3.56e-04 | 104 | 65 | 4 | int:BACC1 | |
| Interaction | RNF113A interactions | 3.61e-04 | 692 | 65 | 9 | int:RNF113A | |
| Interaction | TOP1 interactions | 3.76e-04 | 696 | 65 | 9 | int:TOP1 | |
| Interaction | DDB1 interactions | 3.80e-04 | 697 | 65 | 9 | int:DDB1 | |
| Interaction | SMC1A interactions | 3.88e-04 | 418 | 65 | 7 | int:SMC1A | |
| Interaction | MEN1 interactions | PCF11 WIZ GRWD1 CTCF BAZ2A PRCC YLPM1 SMARCA4 CHD8 CHD4 ZC3H18 | 4.13e-04 | 1029 | 65 | 11 | int:MEN1 |
| Interaction | BPTF interactions | 4.36e-04 | 197 | 65 | 5 | int:BPTF | |
| Interaction | SP7 interactions | 4.39e-04 | 304 | 65 | 6 | int:SP7 | |
| Interaction | SFPQ interactions | 4.39e-04 | 563 | 65 | 8 | int:SFPQ | |
| Interaction | TFIP11 interactions | 4.41e-04 | 427 | 65 | 7 | int:TFIP11 | |
| Interaction | SAP18 interactions | 4.46e-04 | 305 | 65 | 6 | int:SAP18 | |
| Interaction | BRD2 interactions | 4.53e-04 | 429 | 65 | 7 | int:BRD2 | |
| Interaction | LIN9 interactions | 4.56e-04 | 111 | 65 | 4 | int:LIN9 | |
| Interaction | ARID4B interactions | 4.56e-04 | 199 | 65 | 5 | int:ARID4B | |
| Interaction | EP300 interactions | GRWD1 CTCF PRCC USP9X YLPM1 RSF1 RWDD1 SMARCA4 PAK2 CHD4 HNRNPUL1 KDM1A HNRNPU | 4.58e-04 | 1401 | 65 | 13 | int:EP300 |
| Interaction | FYN interactions | 4.66e-04 | 431 | 65 | 7 | int:FYN | |
| Interaction | RUVBL1 interactions | 5.05e-04 | 575 | 65 | 8 | int:RUVBL1 | |
| Interaction | SOX2 interactions | WIZ HNRNPUL2 CTCF USP9X YLPM1 HIP1R PAK1 SMARCA4 PAK2 CHD8 CHD4 KDM1A HNRNPU | 5.27e-04 | 1422 | 65 | 13 | int:SOX2 |
| Interaction | PRPF40A interactions | 5.71e-04 | 446 | 65 | 7 | int:PRPF40A | |
| Interaction | MTF2 interactions | 5.74e-04 | 118 | 65 | 4 | int:MTF2 | |
| Interaction | SCARNA22 interactions | 5.74e-04 | 118 | 65 | 4 | int:SCARNA22 | |
| Interaction | TEK interactions | 5.93e-04 | 119 | 65 | 4 | int:TEK | |
| Interaction | CHAF1A interactions | 5.94e-04 | 322 | 65 | 6 | int:CHAF1A | |
| Interaction | PPP1R12A interactions | 5.94e-04 | 322 | 65 | 6 | int:PPP1R12A | |
| Interaction | ZBTB2 interactions | 6.02e-04 | 450 | 65 | 7 | int:ZBTB2 | |
| Interaction | RCHY1 interactions | 6.24e-04 | 325 | 65 | 6 | int:RCHY1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | SPDYE11 SPDYE17 SPDYE10 SPDYE13 SPDYE15 SPDYE8 SPDYE9 SPDYE12 SPDYE14 | 6.81e-10 | 271 | 75 | 9 | chr7q11 |
| Cytoband | 7q11.23 | 2.03e-05 | 97 | 75 | 4 | 7q11.23 | |
| Cytoband | 11q12.3 | 1.78e-03 | 38 | 75 | 2 | 11q12.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q14 | 2.17e-03 | 156 | 75 | 3 | chr11q14 | |
| Cytoband | 19p13.12 | 3.07e-03 | 50 | 75 | 2 | 19p13.12 | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | 2.53e-06 | 12 | 42 | 3 | 756 | |
| GeneFamily | PHD finger proteins | 5.56e-05 | 90 | 42 | 4 | 88 | |
| GeneFamily | ATP binding cassette subfamily A | 4.71e-04 | 14 | 42 | 2 | 805 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.16e-03 | 36 | 42 | 2 | 823 | |
| GeneFamily | X-linked mental retardation|Angiotensin receptors | 6.73e-03 | 53 | 42 | 2 | 103 | |
| GeneFamily | Ubiquitin specific peptidases | 7.49e-03 | 56 | 42 | 2 | 366 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | 4.81e-07 | 269 | 68 | 8 | M41203 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B|Lung / Manually curated celltypes from each tissue | 4.27e-07 | 182 | 70 | 6 | 310f94437d197eaaaf6e30e68063b33e94befe77 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-B-B_memory|Bac-SEP / Disease, condition lineage and cell class | 7.41e-07 | 200 | 70 | 6 | 7578fc9b6b8519a04c4c08fdfd3224b3df8057a2 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.05e-06 | 158 | 70 | 5 | 41cf950983f47a9e55d56041b301006b42853b37 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.87e-06 | 163 | 70 | 5 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.80e-06 | 168 | 70 | 5 | eeb381b62c7ba263af96de1194ed59e57b6ca3ae | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.80e-06 | 168 | 70 | 5 | 063d0368d656962b335154c230bdcd9236e7c9ad | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.80e-06 | 168 | 70 | 5 | a7c4251d8a83bc30196a444028a35c17c24dc291 | |
| ToppCell | LPS-IL1RA-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.20e-06 | 170 | 70 | 5 | 92e0873f618b2fa60c4d555b10f234d5cbcf3325 | |
| ToppCell | LPS-IL1RA-Lymphocytic_B-B_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.20e-06 | 170 | 70 | 5 | c181991f933b779f99afc3782f292306f209e2ac | |
| ToppCell | LPS-IL1RA-Lymphocytic_B|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.20e-06 | 170 | 70 | 5 | 56284fbfd1e53f67c8c0b7fba64505a4002adba2 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.84e-06 | 173 | 70 | 5 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.07e-06 | 174 | 70 | 5 | cc493654ea3517bc6a145c7f787f304929636f86 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.07e-06 | 174 | 70 | 5 | 9eb3504f9340517ef5d056503044fbdb9ffeb714 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.07e-06 | 174 | 70 | 5 | b4c2d1c029fcd0d4926aa79a5b789c713919dcf3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.07e-06 | 174 | 70 | 5 | 5f4436863a40f8bca46e2989bca66c02b6be88d4 | |
| ToppCell | LPS_only-Lymphocytic_B-B_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.76e-06 | 177 | 70 | 5 | c82332c5f656aa26513e4f7525d5d4d733019725 | |
| ToppCell | LPS_only-Lymphocytic_B|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.76e-06 | 177 | 70 | 5 | 5ed65e08d773d157840317c72e0d43c261d438d4 | |
| ToppCell | LPS_only-Lymphocytic_B-B_cells-B-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.76e-06 | 177 | 70 | 5 | 8a955a7ab84c434f9ad4b467246b8be3cb479406 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.00e-06 | 178 | 70 | 5 | 2e51c1596022b7047994ee13c18375bad19a54a5 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.00e-06 | 178 | 70 | 5 | 6f50e2ee66bd9dc12fd3c9ea70e6d50ff76b02e8 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.00e-06 | 178 | 70 | 5 | b132605f237e766a21042b9a65a564d64c4fec10 | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.00e-06 | 178 | 70 | 5 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.00e-06 | 178 | 70 | 5 | 5d41fede13c8e64b6fdaf2155f1eb72bcfc32fdb | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.00e-06 | 178 | 70 | 5 | 99cd5e517855f1a2d6d75fb2d439751f884862c1 | |
| ToppCell | Severe-Lymphoid-B|Severe / Condition, Lineage, Cell class and cell subclass | 9.51e-06 | 180 | 70 | 5 | 67ffaf5096f025c3c61fffe52f6c8a96f120fc6f | |
| ToppCell | Severe-Lymphoid-B-|Severe / Condition, Lineage, Cell class and cell subclass | 9.51e-06 | 180 | 70 | 5 | fd3eb751704b14ff1500e4bd041441644d233e9c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.51e-06 | 180 | 70 | 5 | 65c069585737302a69b9a01476f4eb8b50cb2bfd | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.76e-06 | 181 | 70 | 5 | 57f20341c3e9f9f6ed5b6c181605ad35bae91414 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.76e-06 | 181 | 70 | 5 | ca34d83daca10c5fa52ecdf4eba7d31b4e7e056e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.76e-06 | 181 | 70 | 5 | 30729f0364f719c044712a51453e22dc2c1a232b | |
| ToppCell | B_cells-Naive_B_cells_|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.00e-05 | 182 | 70 | 5 | 63c3b63315276b66667d49fab09661ac320e7a36 | |
| ToppCell | Severe_COVID-19-B_cell-B_cell|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.03e-05 | 183 | 70 | 5 | 5634e528001c389efd1e380f01ad40072f60e943 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.03e-05 | 183 | 70 | 5 | dbc7ec66da5930c2bf4e0405937b054e04c22a34 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.09e-05 | 185 | 70 | 5 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-05 | 187 | 70 | 5 | 8fa454dc4e6a3e8e2bb2ad803acc579e0d3f76da | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-B_lymphocytic-naive_B_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.14e-05 | 187 | 70 | 5 | 160e5f338537d90d50f863a1be801b1071ac7da7 | |
| ToppCell | Immune-B_cell|World / Lineage, Cell type, age group and donor | 1.14e-05 | 187 | 70 | 5 | 795690c6306c366e733279491138d0cd9b469b21 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-8|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.14e-05 | 187 | 70 | 5 | c10d6a774b3e83f64e47b9ad08f5d6b0dc60d163 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-05 | 187 | 70 | 5 | edad646d5eb1d70b768dc21fe02ef5265214e8e6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.14e-05 | 187 | 70 | 5 | d01926be1c8846a25fb6706e26b56b808b69f8f0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.17e-05 | 188 | 70 | 5 | d8decd9b5967873ca8320c2f9f07365f163c777f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.17e-05 | 188 | 70 | 5 | 5707786cc4452dc34f95db2b3cd29f6e025c0622 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_activate-7|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.20e-05 | 189 | 70 | 5 | ef33cc03728a78423ee92d2ef1ffed4918d4221f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.23e-05 | 190 | 70 | 5 | 112706d64ee73b55dcf76f33ca064ab1fc6ce87f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.23e-05 | 190 | 70 | 5 | 60bb6aaea9691d07295f61c14d1650f5041a0f9c | |
| ToppCell | COVID_vent-Lymphocytic-B_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.23e-05 | 190 | 70 | 5 | 40b5e9e8f8fd8d84cb5b43e67b49267082348e9f | |
| ToppCell | COVID_vent-Lymphocytic-B_cell-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.23e-05 | 190 | 70 | 5 | a37a32dc1b931562a6660074e19d5598efc65284 | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.23e-05 | 190 | 70 | 5 | 424550418c1bd4eb070cf3c41cf09fa9d89aef37 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.23e-05 | 190 | 70 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-B_lymphocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.27e-05 | 191 | 70 | 5 | 3fc16e986aff5e0cd4f831e25e78a5b30beba7a8 | |
| ToppCell | Control-Lymphoid_B|Control / Disease group, lineage and cell class | 1.27e-05 | 191 | 70 | 5 | 0a760cd3a48c487ec899adb882fddea8914cfe0c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-05 | 191 | 70 | 5 | a831e30f37aff329d83fac9bdb84f783075d5df6 | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.27e-05 | 191 | 70 | 5 | 84452125d1b5b76974e3f9126f611eff16d45c25 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.27e-05 | 191 | 70 | 5 | b7d17d3ba488378b30f3732f8109f4a7c1673e61 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-05 | 191 | 70 | 5 | 2453064c39b359088d43d52792bf829f83442c82 | |
| ToppCell | healthy_donor-Lymphocytic-B_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.30e-05 | 192 | 70 | 5 | 7d9e5772b6e531b50ed4e4d6304ef11235f27f37 | |
| ToppCell | Healthy-B_naive|Healthy / disease group, cell group and cell class | 1.30e-05 | 192 | 70 | 5 | 5fddf679dcc9c0077d6bfe04c1e602863fb959eb | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.30e-05 | 192 | 70 | 5 | 89b8ebdc285ed3c0f807fd1157271130d37dfa41 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-13|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.30e-05 | 192 | 70 | 5 | e5ab932b4c2fed538161281ae07dfcdd82706fdd | |
| ToppCell | healthy_donor-Lymphocytic-B_cell-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.30e-05 | 192 | 70 | 5 | 975312f9d6cede4d4f5b737e481e5c73accc8c50 | |
| ToppCell | COVID-19_Severe-Lymphoid_B-B_intermediate|COVID-19_Severe / Disease group, lineage and cell class | 1.33e-05 | 193 | 70 | 5 | ea079e6f7242a2bbc8260299ad9e9bdabb9856f8 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.33e-05 | 193 | 70 | 5 | b5e44fe60dc84dc050d4fa3ccec4e257e51dc636 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.33e-05 | 193 | 70 | 5 | e2cf2f4f142e1b4dda3ded28b5208eef3f301a43 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-9|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.33e-05 | 193 | 70 | 5 | d5d188a314da1b4c8390276d88173c09dd7ce4bf | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.33e-05 | 193 | 70 | 5 | 6e6c5ae39ea880ba809019a7d39f50e4e02007ed | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.33e-05 | 193 | 70 | 5 | c04ac5884be4245b75d211046f04d76ae0cfb998 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.33e-05 | 193 | 70 | 5 | 749faa5c592ee354733f5a7363a4277ef3462b93 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-05 | 194 | 70 | 5 | 7f62bd52779e2779447b23bdd330be4b5b35910a | |
| ToppCell | PBMC-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-05 | 194 | 70 | 5 | b6328575eedb19e0ad7f4d03041672f3dc146da0 | |
| ToppCell | PBMC-Control-Lymphocyte-B|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-05 | 194 | 70 | 5 | a8daf73c186a15adb9ea02793d4bd9cb35c66290 | |
| ToppCell | COVID-19_Moderate-B_naive|COVID-19_Moderate / disease group, cell group and cell class | 1.36e-05 | 194 | 70 | 5 | 8c41a37467bfd4966ecd09dde68c543dc01b6ad0 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-05 | 194 | 70 | 5 | 82753b90ca3b563275c41b6040ebbcd99b185e24 | |
| ToppCell | PBMC-Control-Lymphocyte-B|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.36e-05 | 194 | 70 | 5 | 39121c7d537ac103f6959271d814fd327be7114f | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Immature_B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.36e-05 | 194 | 70 | 5 | f957cec2f309d726e095d18a7da32789dca92a36 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-05 | 194 | 70 | 5 | e9c907b8ec4329946338cca5ce8e954fa2cec37b | |
| ToppCell | COVID-19_Moderate-B_naive|World / disease group, cell group and cell class | 1.36e-05 | 194 | 70 | 5 | 1f81d618799e482a36dce528bba70f52cc69a901 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.36e-05 | 194 | 70 | 5 | 60542304899b99caa38e4abf6b71ba986fa6c399 | |
| ToppCell | Control-Lymphoid_B-B_naive|Control / Disease group, lineage and cell class | 1.36e-05 | 194 | 70 | 5 | 4f9600960a287cfc020c06b4af3528d4e5797916 | |
| ToppCell | COVID-19_Severe-B_naive|World / disease group, cell group and cell class | 1.36e-05 | 194 | 70 | 5 | d363963a6caeedf4f9e9ad22dcf9b66b85c79a48 | |
| ToppCell | PBMC-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.36e-05 | 194 | 70 | 5 | b16b96e42ea9734731342d4c41ff1711bd149462 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-05 | 194 | 70 | 5 | 287439c51528d7bb13bd235875d85631dc91ed91 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-05 | 194 | 70 | 5 | ad9a8cc57f54bdec4cd6990b2cace947b7a163c9 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-CD5-_Mature_B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.40e-05 | 195 | 70 | 5 | fe3f978820a63c26a537d97e69f7999dd60bb0ea | |
| ToppCell | Healthy_donor-B_naive|World / disease group, cell group and cell class (v2) | 1.40e-05 | 195 | 70 | 5 | c66bbfdf0091cc62aa50edfa88820bbda191b7bb | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.40e-05 | 195 | 70 | 5 | b74645072a063732d5be43036ce0e9568eff3d14 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B|bone_marrow / Manually curated celltypes from each tissue | 1.40e-05 | 195 | 70 | 5 | bcbf0305ca9337a6f3021178dbb47a7fbf1030a4 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.40e-05 | 195 | 70 | 5 | 8f5a664dd65c38afe23c6acd0a9c22ba4fd347ed | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.40e-05 | 195 | 70 | 5 | e830f0c545be87a1056a4505bdf6845e5ac7750d | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.40e-05 | 195 | 70 | 5 | 4b882a71f0e02fef5580e9d9bc42245cf9df2e57 | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_naive|World / disease group, cell group and cell class (v2) | 1.40e-05 | 195 | 70 | 5 | e763d9a431052c03cc6d514f2736506c6667e2be | |
| ToppCell | COVID-19_Severe-Lymphoid_B-B_naive|COVID-19_Severe / Disease group, lineage and cell class | 1.40e-05 | 195 | 70 | 5 | 71563e838fcda34a9a209c5433e0d84420373402 | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_naive|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.43e-05 | 196 | 70 | 5 | c87499aa570f8fab878c4c015e47c711a3a21e9c | |
| ToppCell | Healthy/Control-B_naive|Healthy/Control / Disease group and Cell class | 1.43e-05 | 196 | 70 | 5 | e92d2c814d2dcb049f3e455fe66fd40898b3524d | |
| ToppCell | Healthy_donor-B_naive|Healthy_donor / disease group, cell group and cell class (v2) | 1.43e-05 | 196 | 70 | 5 | cf254b1466357984201595fa32408d659eb741ef | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.43e-05 | 196 | 70 | 5 | d7e6c89cb49933b4a86d26d15f6772f2481d37ef | |
| ToppCell | COVID-19_Mild-Lymphoid_B-B_naive|COVID-19_Mild / Disease group, lineage and cell class | 1.43e-05 | 196 | 70 | 5 | 4b3ceb1f85be0fa8d53dc5548326ab0a5239a8b9 | |
| ToppCell | Healthy/Control-B_naive|World / Disease group and Cell class | 1.43e-05 | 196 | 70 | 5 | ec935a4e16495c87b17070eb13c1e28bdb64e7ee | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.43e-05 | 196 | 70 | 5 | fcbfd8c4771d99a45fc53e482ef98edabe8ef591 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.43e-05 | 196 | 70 | 5 | f45cb8f714ae7ac800768df65f299b98a2d42962 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.43e-05 | 196 | 70 | 5 | de43dd0697e1daf4d50800957cf0b27b54a7a333 | |
| Drug | PHA-00851261E [724719-49-7]; Up 200; 1uM; PC3; HT_HG-U133A | 1.71e-06 | 198 | 66 | 7 | 4333_UP | |
| Drug | Azathymine, 6 [932-53-6]; Up 200; 31.4uM; MCF7; HT_HG-U133A | 2.23e-05 | 196 | 66 | 6 | 4106_UP | |
| Drug | Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; PC3; HT_HG-U133A | 2.29e-05 | 197 | 66 | 6 | 5867_DN | |
| Drug | Tiletamine hydrochloride; Up 200; 15.4uM; MCF7; HT_HG-U133A | 2.36e-05 | 198 | 66 | 6 | 6013_UP | |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; HL60; HG-U133A | 2.36e-05 | 198 | 66 | 6 | 1415_DN | |
| Disease | Mental Retardation, X-Linked 1 | 4.40e-05 | 32 | 63 | 3 | C2931498 | |
| Disease | female breast cancer (is_implicated_in) | 1.25e-04 | 8 | 63 | 2 | DOID:0050671 (is_implicated_in) | |
| Disease | parental longevity | 6.48e-04 | 494 | 63 | 6 | EFO_0007796 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 7.49e-04 | 19 | 63 | 2 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 7.49e-04 | 19 | 63 | 2 | C2936783 | |
| Disease | Neoplasm of the genitourinary tract | 1.20e-03 | 24 | 63 | 2 | cv:C0042065 | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 1.41e-03 | 26 | 63 | 2 | C0009405 | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 1.52e-03 | 27 | 63 | 2 | C1112155 | |
| Disease | preterm premature rupture of the membranes, spontaneous preterm birth | 1.64e-03 | 28 | 63 | 2 | EFO_0006917, MONDO_0012511 | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 1.76e-03 | 29 | 63 | 2 | C1333990 | |
| Disease | esophageal carcinoma | 1.88e-03 | 30 | 63 | 2 | EFO_0002916 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PEPPDNEDEDEDVKA | 1256 | Q8WWZ7 | |
| DEGEQPAPEEDELEE | 1246 | Q9P281 | |
| LPPLQPEEDDDEDEE | 2531 | Q9HCK8 | |
| EPDLDDNEDEEEPAV | 616 | P49711 | |
| EPDAEPAEGEEEEAQ | 691 | P49711 | |
| HPNPEEPEEEDEDVQ | 1161 | Q8WWZ4 | |
| EEPEPDEAESSPDPQ | 1306 | Q9UIF9 | |
| EDQEPEDQEPEEPTP | 76 | O96017 | |
| EEEETETNFPEPPQD | 271 | P11836 | |
| PPPEDYEEEEAAVVE | 421 | Q9NYB9 | |
| EPPNEDDEDDDEALP | 66 | A6NK89 | |
| IPSPPEDDEEEDNDE | 506 | Q9Y3P9 | |
| EEPDAEEPATEEPTA | 226 | Q5JQC4 | |
| EEEEEEEDENEPPPV | 191 | O75914 | |
| PPPSEGSDEEEEEED | 116 | Q9BQ67 | |
| PPEPACEDADEDEDD | 141 | O43561 | |
| ENEEEEEEEEQPPPT | 46 | Q96D96 | |
| PNLIPENGDEEEEED | 476 | Q9H165 | |
| TDDPEEEEEEAPAPN | 1036 | Q14432 | |
| DPEPPETSEEEEEEE | 26 | A0A1W2PR82 | |
| SPQPPVEEEDEHFDD | 271 | Q00839 | |
| EEALLEDEDEEPPPA | 86 | Q1KMD3 | |
| PFEDDEEEEPAVPEV | 311 | Q8IYI6 | |
| QSPEDEDEGPAEEVP | 451 | Q86Y91 | |
| GEEEEEEDEPDPEAP | 101 | Q8IZP7 | |
| DPESEEEPDLPEVDV | 361 | P48551 | |
| PPPEEEEDQNEDQDV | 1301 | O94913 | |
| ETPAVPPVSEDEDDD | 166 | Q13153 | |
| DEDDDDDDATPPPVI | 176 | Q13153 | |
| EEDDDEETAPPVIAP | 171 | Q13177 | |
| PEEAPEDEEPENLIE | 306 | O75146 | |
| PQAPPEEENESEPEE | 156 | O60341 | |
| AGDPEPESEAEPEAE | 556 | Q2V2M9 | |
| ANQDEGPEDEEDEVP | 436 | Q6P1N0 | |
| DEETEPLDGDEVADP | 116 | Q5T0F9 | |
| DPSQSDDPDDPDDPD | 56 | Q8TF76 | |
| EEEEEDDWEPPTSPA | 846 | Q9C0E4 | |
| PHPENEEDPEEDLSE | 31 | Q14839 | |
| VSDENPDESEEDPPS | 1121 | Q96T23 | |
| PDESEEDPPSNDDSD | 1126 | Q96T23 | |
| ADPDQPREDPAEEEK | 461 | Q08357 | |
| QPPAEEDEDDFDDTL | 196 | Q9BUJ2 | |
| HLPDPPLESEDEDEE | 106 | Q16626 | |
| EEEPDDQDAPDEHES | 2476 | Q93008 | |
| DQDAPDEHESPPPED | 2481 | Q93008 | |
| ESEPDEAEPEPEEEE | 11 | Q92733 | |
| EAEPEPEEEEAVAPT | 16 | Q92733 | |
| HEDNEETEETPVPEP | 301 | Q8NFB2 | |
| EPEPEPVEANSEESD | 176 | Q5JRA6 | |
| EEEEEEEQPQAAQPP | 666 | P51532 | |
| DESDDEPEKELAPEP | 66 | P0DUX0 | |
| DESDDEPEKELAPEP | 66 | P0DTA3 | |
| DESDDEPEKELAPEP | 66 | P0DUD1 | |
| EDDPESEPEGQDIDE | 261 | Q149N8 | |
| EGVASPDEDEDEEPA | 251 | O95785 | |
| PDEDEDEEPAVFPCI | 256 | O95785 | |
| EEVPAEEQDPSPEAA | 326 | Q13438 | |
| PMEEDEQHSEADEPP | 1956 | Q8NFU7 | |
| PDFDPEEDEPTLEAS | 141 | Q15172 | |
| PDPPGTMEEEEEDDD | 11 | Q6ZS10 | |
| EVEPEPNPEEAETES | 36 | Q14028 | |
| DPQDDVQPPEVEEEE | 866 | Q8WXI2 | |
| EDEEPAQEEPEPITA | 691 | Q9BZQ8 | |
| EPHEEDRTEPPEEFD | 1306 | Q6ZVD8 | |
| EAEEEAQPEPEGVET | 2216 | Q8IWN7 | |
| DESDDEPEKELAPEP | 66 | P0DUX1 | |
| DESDDEPEKELAPEP | 66 | A0A494C0Z2 | |
| DESDDEPEKELAPEP | 66 | P0DUD3 | |
| DESDDEPEKELAPEP | 66 | P0DUD4 | |
| DESDDEPEKELAPEP | 66 | P0DUD2 | |
| DESDDEPEKELAPEP | 131 | A6NKU9 | |
| SDDEPEKELAPEPEE | 206 | A6NKU9 | |
| ESDDEPEKELAPEPE | 351 | A6NKU9 | |
| PEEEPDDQDAPDEHE | 2476 | O00507 | |
| DDQDAPDEHEPSPSE | 2481 | O00507 | |
| EHEDDPDVDEPLETP | 41 | Q04323 | |
| DDDDDDSPDPESPDD | 121 | O00193 | |
| PEEPQSEDPEEDARL | 366 | P49750 | |
| DESDDEPEKELAPEP | 66 | A0A494C191 | |
| EEEEEEEAAPDPAAA | 26 | A0PJX2 | |
| DEEPQQEEPPTESRD | 31 | Q8WTP9 | |
| DEDDPDYNPADPESD | 226 | Q9H446 | |
| DEEVPEEPAPAVQED | 131 | Q86VM9 | |
| DDADYEPPPSNDEEA | 141 | Q13094 | |
| PEEEEEEAVADPDPG | 331 | O15069 | |
| CQDPQEDSVEDEEPP | 1251 | O15069 | |
| PEQQEDEDSLEEDSP | 1346 | O15069 |